Tetanus Toxoid Vaccine Market Trends

Statistics for the 2023 & 2024 Tetanus Toxoid Vaccine market trends, created by Mordor Intelligence™ Industry Reports. Tetanus Toxoid Vaccine trend report includes a market forecast to 2029 and historical overview. Get a sample of this industry trends analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Trends of Tetanus Toxoid Vaccine Industry

The Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Segment is Expected to Hold a Significant Market Share in the Tetanus Toxoid Vaccine Market During the Forecast Period

The diphtheria, tetanus, and pertussis (DTaP) vaccine segment is anticipated to witness growth in the tetanus toxoid vaccine market owing to factors such as growing government initiatives to eradicate these diseases, a rise in product launches, and an increase in pipeline studies for the development of DTaP vaccines. The DTaP vaccine protects young children against diphtheria, tetanus, and whooping cough (pertussis), three potentially fatal illnesses.

Due to the significant burden of diphtheria, tetanus, and pertussis cases is likely to fuel the demands for diphtheria, tetanus, and pertussis (DTaP) vaccines and boost the segment growth. For instance, according to a vaccine-preventable disease update by the World Health Organization (WHO) in October 2022, seven countries (Austria, France, Germany, Italy, Norway, Switzerland, and the United Kingdom) reported 144 cases of diphtheria, many of which were among asylum seekers. Of the 144 cases, 97 (69%) were classified as clinically compatible, 44 (31%) were laboratory-confirmed as toxigenic diphtheria cases, and 3 (2%) were suspected cases. Moreover, as per an August 2023 update from the World Health Organization (WHO), in 2022, a significant 84% of infants around the globe were protected against severe diseases like diphtheria, tetanus, and pertussis by receiving three doses of the DTP vaccine. Also, per the 2023 Provisional Pertussis Surveillance Report published by the Centers for Disease Control and Prevention (CDC), 5,611 cases of pertussis were reported in the United States in 2023, up from 2,388 cases in 2022. Hence, an increase in pertussis cases is likely to demand vaccine availability, thereby driving the segment growth.

Additionally, government initiatives to increase the accessibility of the diphtheria-tetanus-pertussis (DTP) vaccine are anticipated to boost the segment's growth. For instance, in December 2023, eligible Gavi-supported countries can now submit applications to incorporate diphtheria, tetanus, and pertussis (DTP)-containing booster doses (DTP boosters) into their immunization schedules. Thus, such initiatives are anticipated to boost the adoption of diphtheria, tetanus, and pertussis (DTP) vaccines and fuel the segment growth.

Therefore, due to factors such as the growing burden of diphtheria, tetanus, and pertussis, government initiatives are likely to impact the market growth positively.

Tetanus Toxoid Vaccine Market: Percentage of Immunization Coverage, By Selected Antigens, Global, 2022

North America is Expected to Hold a Significant Share in the Market During the Forecast Period

North America is expected to hold a significant market share in the tetanus toxoid vaccine market due to the increase in government vaccination programs, the surge in diphtheria, pertussis, and tetanus cases, and the rise in research initiatives for vaccine development.

The high prevalence of pertussis cases in the region drives the demand for tetanus toxoid vaccines and boosts market growth. For instance, according to a January 2024 update from the Department of Minnesota, 61 cases of pertussis were reported in the Minnesota region till December 2023. Also, as per the Florida Health Report, in 2023, 10 pertussis cases were reported in 6 counties. A 10% increase in pertussis cases was reported between August 2022 and January 2023 compared to August 2021 and January 2022. Thus, the increase in the prevalence of pertussis cases in the region is expected to fuel the need for tetanus toxoid vaccines and contribute to the market growth.

Also, the rise in government initiatives for vaccinations against tetanus and diphtheria is expected to boost the market growth during the forecast period. For instance, in April 2022, Ontario expanded its publicly funded Tdap immunization program to include a routine dose in every pregnancy for protection against pertussis, regardless of previous Tdap immunization history. Canada's National Advisory Committee on Immunization recommended that all pregnant individuals get the pertussis (whooping cough) vaccine during each pregnancy to safeguard newborns after birth.

Tetanus Toxoid Vaccine Market - Growth Rate by Region

Tetanus Toxoid Vaccine Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)